Form 4: Aveanna Healthcare Director Erica Schwartz Acquires Shares Through Restricted Stock Unit Grant

Director Erica Schwartz acquired 28,261 shares of Aveanna Healthcare Holdings, Inc. through a restricted stock unit grant that vests in one year.

Summary

• On February 28, 2025, Erica Schwartz, a director of Aveanna Healthcare Holdings, Inc., acquired 28,261 shares of common stock.
• The acquisition was a grant of stock-settled restricted stock units, priced at $0.
• Following the transaction, Schwartz directly owns 257,498 shares of Aveanna Healthcare Holdings, Inc.
• A Power of Attorney was executed on February 21, 2024, appointing Jonathan Beckler, Deborah Stewart, and Matthew Buckhalter as attorneys-in-fact for Erica Schwartz for SEC filings.
• This Power of Attorney revokes a previous one dated July 6, 2021.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard insider transaction disclosure. The acquisition of shares by a director is generally viewed positively, but it's not a major event.

Positives

• The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future prospects.

Future Outlook

The restricted stock units are subject to a one-year cliff vesting period, suggesting a commitment to the company for at least one year.

Industry Context

Form 4 filings are routine disclosures required by the SEC when insiders, such as directors and officers, trade their company's stock. These filings provide transparency to the market.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment due to the director's increased stake in the company.

Key Dates